Rajbir Sidhu, MD
Cardiovascular Disease (Cardiology) · Castro Valley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 13
Offices
13 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Eden Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Sidhu’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A155167 · Current
Licensed to practise in California · since 2018 · expires 2027-07-31 · Drexel University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$211,419
Medicare paid this office $211,419 for 1,142 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 195 | $38,421 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 181 | $34,795 | $104 |
| Long return visit (40+ min) | 177 | $34,254 | $156 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 382 | $24,276 | $58 |
| Return visit (30+ min) | 138 | $17,253 | $113 |
See all 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 195 | $38,421 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 181 | $34,795 | $104 |
| Long return visit (40+ min) | 177 | $34,254 | $156 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 382 | $24,276 | $58 |
| Return visit (30+ min) | 138 | $17,253 | $113 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 101 | $15,778 | $153 |
| Critical care, first 30-74 minutes | 36 | $12,297 | $184 |
| New patient visit (60+ min) | 55 | $9,934 | $181 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 29 | $6,958 | $240 |
| New patient visit (45+ min) | 14 | $2,146 | $153 |
| Heart muscle strain imaging | 50 | $1,924 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 110 | $1,386 | $12 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,113 | $93 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 13 | $736 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $607 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 20 | $524 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 42 | $492 | $12 |
| Ultrasound of heart, follow-up | 16 | $350 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $244 | $19 |
Who their Medicare patients are
1,142 Original Medicare patients in 2024. Average age 77 · Under 65 6% · 85 and older 21% · Women 54% · Also on Medicaid 35% · Health risk score 2.06. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 45% · Chronic kidney disease 43% · Heart failure 42% · Diabetes 40% · Atrial fibrillation 40% · Depression 25% · Stroke 25% · COPD 21% · Cancer 20% · Dementia 16%.
The office billed $872,723, Medicare allowed $275,884 and paid $211,419; for 2,049 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,142 | 2,049 | 77 | 2.06 | $872,723 | $211,419 |
| 2023 | 1,887 | 3,789 | 77 | 1.77 | $1,623,421 | $299,218 |
| 2022 | 1,871 | 3,797 | 76 | 1.56 | $1,473,951 | $293,365 |
| 2021 | 719 | 1,185 | 76 | 1.57 | $404,471 | $84,743 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 32 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 665 | $64,090 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 222 | $43,137 | $105 |
| Long return visit (40+ min) | 221 | $33,186 | $127 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 100 | $26,247 | $262 |
| New patient visit (60+ min) | 169 | $25,847 | $153 |
| Critical care, first 30-74 minutes | 54 | $18,329 | $185 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $15,771 | $153 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 223 | $13,739 | $61 |
| Return visit (30+ min) | 151 | $12,302 | $77 |
| Injection, regadenoson, 0.1 mg | 49 | $7,915 | None |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 50 | $5,089 | $51 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 57 | $3,175 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 52 | $3,151 | $61 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 14 | $3,001 | $214 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 14 | $2,387 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 357 | $2,353 | $6 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,070 | $115 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,317 | $94 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 110 | $1,302 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 70 | $1,235 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $1,219 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 19 | $1,183 | $23 |
| Programming of dual lead pacemaker system | 19 | $1,124 | $49 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $1,035 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 60 | $832 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 45 | $647 | $14 |
| Ultrasound of heart, follow-up | 14 | $309 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 54 | $251 | $5 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $237 | $16 |
| Injection, aminophyllin, up to 250 mg | 14 | $97 | None |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 13 | $81 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $74 | $3 |
2022: 29 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 482 | $51,050 | $105 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 126 | $39,962 | $317 |
| New patient visit (60+ min) | 211 | $30,286 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 180 | $28,687 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 125 | $22,359 | $172 |
| Long return visit (40+ min) | 145 | $20,306 | $115 |
| Return visit (30+ min) | 169 | $16,467 | $85 |
| Critical care, first 30-74 minutes | 33 | $16,259 | $189 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 252 | $15,690 | $62 |
| Injection, regadenoson, 0.1 mg | 73 | $14,010 | None |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 79 | $7,783 | $49 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 79 | $4,745 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 581 | $3,788 | $6 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $2,737 | $211 |
| New patient visit (45+ min) | 20 | $2,150 | $107 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $1,989 | $22 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 29 | $1,585 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 78 | $1,465 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 95 | $1,201 | $13 |
| Short return visit (20+ min) | 17 | $1,000 | $59 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 16 | $866 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 15 | $804 | $24 |
| Programming of dual lead pacemaker system | 13 | $729 | $52 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 47 | $637 | $13 |
| Heart muscle strain imaging | 11 | $427 | $39 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 32 | $331 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 14 | $308 | $22 |
| Injection, aminophyllin, up to 250 mg | 30 | $227 | None |
| Ultrasound of heart blood flow, valves and chambers | 16 | $225 | $14 |
2021: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 119 | $16,710 | $140 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $10,850 | $93 |
| New patient visit (60+ min) | 62 | $10,675 | $172 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,153 | $177 |
| Critical care, first 30-74 minutes | 12 | $7,728 | $193 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 90 | $5,871 | $64 |
| Long return visit (40+ min) | 37 | $5,093 | $131 |
| New patient visit (45+ min) | 32 | $3,974 | $124 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 26 | $3,122 | $120 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 278 | $2,093 | $7 |
| Return visit (30+ min) | 16 | $1,556 | $97 |
| Ultrasound of heart | 29 | $1,183 | $41 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 15 | $957 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 46 | $907 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 55 | $727 | $13 |
| Ultrasound of heart, follow-up | 11 | $274 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $200 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 17 | $127 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $108 | $8 |
Medicaid work
$10,126 in 2024
Medicaid paid $10,126 for 405 billed services this clinician did in 2024, up to 50 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 383 | $9,613 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 22 | $513 |
| 2024 | 405 | 2 | 50 | $10,126 |
| 2023 | 703 | 2 | 81 | $21,877 |
| 2022 | 429 | 5 | 47 | $21,042 |
| 2021 | 84 | 1 | 36 | $3,513 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 554 | $16,592 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 149 | $5,285 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 348 | $10,404 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 23 | $7,134 |
| Injection, regadenoson, 0.1 mg | 16 | $2,533 |
| Tc99m sestamibi | 12 | $624 |
| CARDIOVASCULAR STRESS TEST | 30 | $347 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 84 | $3,513 |
Drugs they prescribed that Part D paid
$242,969
Pharmacies billed $242,969 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 991) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
810 generic and 181 brand-name prescriptions · $242,969 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 87 | $121,109 | $1,392 |
| Entresto | 22 | $32,936 | $1,497 |
| Xarelto | 24 | $31,369 | $1,307 |
| Farxiga | 17 | $21,721 | $1,278 |
| Metoprolol | 106 | $1,699 | $16 |
See all 24 drugs
| Eliquis | 87 | $121,109 | $1,392 |
| Entresto | 22 | $32,936 | $1,497 |
| Xarelto | 24 | $31,369 | $1,307 |
| Farxiga | 17 | $21,721 | $1,278 |
| Metoprolol | 106 | $1,699 | $16 |
| Atorvastatin | 119 | $1,616 | $14 |
| Potassium Chloride | 22 | $1,508 | $69 |
| Flecainide Acetate | 16 | $843 | $53 |
| Losartan | 54 | $688 | $13 |
| Amlodipine Besylate | 72 | $602 | $8 |
| Ezetimibe | 15 | $578 | $39 |
| Diltiazem 24hr Er (Cd) | 13 | $530 | $41 |
| Lisinopril | 43 | $461 | $11 |
| Rosuvastatin | 26 | $448 | $17 |
| Clopidogrel | 14 | $292 | $21 |
| Metoprolol | 44 | $287 | $7 |
| Carvedilol | 36 | $284 | $8 |
| Isosorbide Mononitrate Er | 19 | $268 | $14 |
| Amiodarone | 11 | $198 | $18 |
| Losartan-Hydrochlorothiazide | 17 | $193 | $11 |
| Pravastatin | 15 | $163 | $11 |
| Spironolactone | 32 | $149 | $5 |
| Furosemide | 38 | $145 | $4 |
| Hydrochlorothiazide | 18 | $113 | $6 |
Year by year
| 2024 | 991 | 247 | 0% (0) | 18% | $242,969 |
| 2023 | 945 | 254 | 0% (0) | 17% | $212,248 |
| 2022 | 594 | 195 | 0% (0) | 15% | $106,847 |
| 2021 | 256 | 78 | 0% (0) | 18% | $40,106 |
| 2020 | 191 | 43 | 0% (0) | 17% | $20,457 |
| 2019 | 207 | 53 | 0% (0) | 13% | $11,234 |
| 2017 | 21 | None | 0% (0) | None | $1,331 |
| 2016 | 19 | None | 0% (0) | None | $920 |
| 2015 | 26 | 14 | 0% (0) | None | $1,081 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Eliquis | 85 | $105,609 | $1,242 |
| Xarelto | 21 | $32,548 | $1,550 |
| Entresto | 16 | $22,592 | $1,412 |
| Atorvastatin | 139 | $2,120 | $15 |
| Metoprolol | 98 | $2,031 | $21 |
| Carvedilol | 54 | $1,189 | $22 |
| Potassium Chloride | 16 | $1,034 | $65 |
| Amlodipine Besylate | 65 | $656 | $10 |
| Isosorbide Mononitrate Er | 21 | $642 | $31 |
| Digoxin | 12 | $612 | $51 |
| Losartan | 27 | $545 | $20 |
| Hydralazine | 22 | $529 | $24 |
| Rosuvastatin | 31 | $517 | $17 |
| Lisinopril | 37 | $400 | $11 |
| Furosemide | 51 | $394 | $8 |
| Clopidogrel | 16 | $364 | $23 |
| Losartan-Hydrochlorothiazide | 14 | $293 | $21 |
| Spironolactone | 20 | $276 | $14 |
| Metoprolol | 27 | $247 | $9 |
| Hydrochlorothiazide | 19 | $133 | $7 |
2022: 15 drugs
| Eliquis | 48 | $61,133 | $1,274 |
| Metoprolol | 76 | $1,456 | $19 |
| Atorvastatin | 86 | $1,038 | $12 |
| Diltiazem 24hr Er (Cd) | 13 | $644 | $50 |
| Losartan | 29 | $537 | $19 |
| Amlodipine Besylate | 34 | $463 | $14 |
| Lisinopril | 28 | $405 | $14 |
| Isosorbide Mononitrate Er | 13 | $395 | $30 |
| Rosuvastatin | 14 | $395 | $28 |
| Furosemide | 42 | $272 | $6 |
| Clopidogrel | 15 | $271 | $18 |
| Carvedilol | 29 | $267 | $9 |
| Metoprolol | 24 | $159 | $7 |
| Spironolactone | 14 | $130 | $9 |
| Hydrochlorothiazide | 18 | $35 | $2 |
2021: 11 drugs
| Eliquis | 12 | $11,199 | $933 |
| Bumetanide | 11 | $758 | $69 |
| Metoprolol | 28 | $598 | $21 |
| Losartan | 18 | $414 | $23 |
| Atorvastatin | 27 | $342 | $13 |
| Metoprolol | 17 | $201 | $12 |
| Carvedilol | 12 | $201 | $17 |
| Amlodipine Besylate | 11 | $126 | $11 |
| Sotalol | 15 | $116 | $8 |
| Furosemide | 13 | $107 | $8 |
| Clopidogrel | 13 | $104 | $8 |
2020: 7 drugs
| Eliquis | 12 | $6,326 | $527 |
| Metoprolol | 19 | $456 | $24 |
| Atorvastatin | 18 | $432 | $24 |
| Clopidogrel | 19 | $291 | $15 |
| Losartan | 11 | $211 | $19 |
| Sotalol | 14 | $132 | $9 |
| Hydrochlorothiazide | 11 | $64 | $6 |
2019: 5 drugs
| Atorvastatin | 25 | $484 | $19 |
| Metoprolol | 13 | $130 | $10 |
| Clopidogrel | 11 | $116 | $11 |
| Carvedilol | 17 | $112 | $7 |
| Metoprolol | 17 | $75 | $4 |
Money from drug and device companies
$15 in 2022
| 2022 | 1 | 1 | None | $15 |
| 2021 | 9 | 28 | None | $643 |
| 2020 | 4 | 7 | None | $149 |
| 2019 | 7 | 17 | None | $601 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Vyndaqel | $15 | 1 payment
|
See the published payment
| Pfizer | Meals · 2022-01-18 | Vyndaqel | $15 |
See earlier years (2021, 2020, 2019)
2021: $643
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $213 | 10 payments
|
| Pfizer | Eliquis | $161 | 8 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $129 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $40 | 2 payments
|
| Boston Scientific | General Therapies | $23 | 1 payment
|
| Abbott Laboratories | Cardiomems Hf System | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $21 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $20 | 1 payment
|
| Kiniksa Pharmaceuticals | None | $14 | 1 payment
|
2020: $149
| Pfizer | Vyndaqel | $89 | 4 payments
|
| Boston Scientific | Vigilant | $26 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $17 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $16 | 1 payment
|
2019: $601
| Alnylam Pharmaceuticals | Onpattro | $237 | 2 payments
|
| Boston Scientific | Vigilant | $155 | 7 payments
|
| Amgen | Corlanor | $67 | 2 payments
|
| Abbott Laboratories | Xience Sierra Coronary Stent System | $63 | 1 payment
|
| Lantheus Medical Imaging | Definity | $31 | 2 payments
|
| Pfizer | Eliquis | $31 | 2 payments
|
| Otsuka America Pharmaceutical | Samsca | $18 | 1 payment
|
Professional record
- NPI
- 1164818118
- Licence
- CA A155167California A155167: Current · expires 2027-07-31
- Trained
- Drexel University College of Medicine, 2015
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Hospitalist (208M00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2015-04-07
- NPI last updated
- 2024-10-14
- NPI record certified
- 2024-10-14
This is when the NPI record was last certified, not a medical board exam.